The boom­ing Boston/Cam­bridge biotech hub claims an in­dus­try-lead­ing role — no­body beats it at rais­ing record amounts of mon­ey

If there’s one thing that the biotech hub crowd in Boston/Cam­bridge is par­tic­u­lar­ly good at, it’s rais­ing mon­ey. Af­ter cre­at­ing one of the biggest con­cen­tra­tions of drug de­vel­op­ment op­er­a­tions in the world in and around greater Boston, the mon­ey-rais­ing side of the busi­ness is now hum­ming like a well-oiled ma­chine.

In a new in­dus­try hub snap­shot out this morn­ing, the Mass­a­chu­setts Biotech­nol­o­gy Coun­cil — bet­ter known as Mass­Bio — hap­pi­ly boast­ed about the fact that 48% of all US biotech IPOs oc­curred in­side the state in 2017. In 2016, it was 30%. 

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.